A detailed history of Woodline Partners LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,565,322 shares of TGTX stock, worth $82.8 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
2,565,322
Previous 1,419,534 80.72%
Holding current value
$82.8 Million
Previous $25.3 Million 137.6%
% of portfolio
0.54%
Previous 0.25%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $19.7 Million - $29 Million
1,145,788 Added 80.72%
2,565,322 $60 Million
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $198,960 - $286,641
14,937 Added 1.06%
1,419,534 $25.3 Million
Q1 2024

May 15, 2024

SELL
$13.02 - $21.3 $4.74 Million - $7.75 Million
-363,837 Reduced 20.57%
1,404,597 $21.4 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $10.8 Million - $30.4 Million
1,616,295 Added 1062.38%
1,768,434 $30.2 Million
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $88,942 - $281,933
10,639 Added 7.52%
152,139 $1.27 Million
Q2 2023

Aug 14, 2023

BUY
$15.48 - $35.0 $2.19 Million - $4.95 Million
141,500 New
141,500 $3.51 Million
Q4 2022

Feb 14, 2023

BUY
$5.01 - $11.83 $8.15 Million - $19.3 Million
1,627,664 Added 174.19%
2,562,100 $30.3 Million
Q3 2022

Nov 14, 2022

BUY
$4.57 - $8.4 $4.27 Million - $7.85 Million
934,436 New
934,436 $5.53 Million
Q4 2021

Feb 14, 2022

SELL
$15.2 - $35.51 $1.63 Million - $3.8 Million
-106,932 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$21.78 - $40.45 $107,854 - $200,308
4,952 Added 4.86%
106,932 $3.56 Million
Q2 2021

Aug 16, 2021

SELL
$32.5 - $48.96 $26.8 Million - $40.4 Million
-824,786 Reduced 89.0%
101,980 $3.96 Million
Q1 2021

May 17, 2021

BUY
$41.61 - $54.3 $37.2 Million - $48.5 Million
893,514 Added 2687.1%
926,766 $44.7 Million
Q4 2020

Feb 16, 2021

SELL
$25.27 - $54.9 $4.21 Million - $9.15 Million
-166,623 Reduced 83.36%
33,252 $1.73 Million
Q3 2020

Nov 16, 2020

SELL
$18.49 - $27.24 $2.46 Million - $3.62 Million
-132,777 Reduced 39.91%
199,875 $5.35 Million
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $2.96 Million - $7.27 Million
332,652 New
332,652 $6.48 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.69B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.